ClinicalTrials.gov record
Potential Benefit for Non Invasive Vagus Nerve Stimulation Using GammaCore in the Treatment of Raynaud's Phenomena.
TERMINATED · NCT03869008
Trial record
NCT IDNCT03869008
Status
TERMINATED
Study type
INTERVENTIONAL
Phase
NA
Enrollment
6
Conditions
Raynaud Phenomenon, Primary Raynaud Phenomenon, Raynaud Disease, Raynaud Syndrome
Interventions
gammaCore Sapphire, Sham Device
Locations
Unversity of Toledo Medical Center, Toledo, Ohio, United States
Indexed topics
Last update
2025-06-25